{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:13:54Z","timestamp":1787066034719,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaci.2025.04.020","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:18:21Z","timestamp":1745749101000},"page":"205-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Complement dysregulation at lymphatics"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9065-1901","authenticated-orcid":false,"given":"Ahmet","family":"Ozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asena Pinar","family":"Sefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmiye Keser","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkay Cagan","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.04.020_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.tibs.2010.04.006","article-title":"Proteolytic cascades and their involvement in invertebrate immunity","volume":"35","author":"Cerenius","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jaci.2025.04.020_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaci.2025.04.020_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/325545a0","article-title":"Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins","volume":"325","author":"Caras","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.04.020_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJMoa1615887","article-title":"CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis","volume":"377","author":"Ozen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.04.020_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJMc1707173","article-title":"Loss of CD55 in eculizumab-responsive protein-losing enteropathy","volume":"377","author":"Kurolap","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.04.020_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/imr.12715","article-title":"CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann\u2019s disease","volume":"287","author":"Ozen","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2025.04.020_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41590-020-00830-z","article-title":"Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease","volume":"22","author":"Ozen","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib10","doi-asserted-by":"crossref","first-page":"P645","DOI":"10.1016\/S0140-6736(23)02358-9","article-title":"Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study","volume":"403","author":"Ozen","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.04.020_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nri3761","article-title":"Complement--tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2025.04.020_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.imbio.2018.02.001","article-title":"Looking back on the alternative complement pathway","volume":"223","author":"Lachmann","year":"2018","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2025.04.020_bib14","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.4049\/jimmunol.1403068","article-title":"Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth","volume":"194","author":"Coulthard","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib15","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/s41467-019-10058-7","article-title":"Single-molecule kinetics of pore assembly by the membrane attack complex","volume":"10","author":"Parsons","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.04.020_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.04.020_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.blre.2017.02.003","article-title":"Complementopathies","volume":"31","author":"Baines","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.jaci.2025.04.020_bib18","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: can we view them separately?","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.04.020_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.153.3.665","article-title":"Activation of the classical pathway of complement by Hageman factor fragment","volume":"153","author":"Ghebrehiwet","year":"1981","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.04.020_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.129.2.315","article-title":"The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor","volume":"129","author":"Ratnoff","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.04.020_bib21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.04.020_bib22","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/j.molimm.2008.03.008","article-title":"Evidence for non-traditional activation of complement factor C3 during murine liver regeneration","volume":"45","author":"Clark","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib23","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaci.2025.04.020_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2025.04.020_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000623","article-title":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2","volume":"2","author":"Krarup","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.04.020_bib26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V68.4.875.875","article-title":"Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase","volume":"68","author":"Wiedmer","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.04.020_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The state of complement in COVID-19","volume":"22","author":"Afzali","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib28","first-page":"1544","article-title":"FDA approves vilobelimab for emergency use in hospitalized adults","volume":"329","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2025.04.020_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13023-024-03436-y","article-title":"The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition","volume":"20","author":"Litcher-Kelly","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2025.04.020_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10875-020-00910-7","article-title":"Eculizumab-responsive adult onset protein losing enteropathy, caused by germline CD55-deficiency and complicated by aggressive angiosarcoma","volume":"41","author":"Hagin","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib31","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/ibd\/izac001","article-title":"Novel CD55 mutation associated with severe small bowel ulceration mimicking inflammatory bowel disease in a pair of siblings","volume":"28","author":"Chongsrisawat","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2025.04.020_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00439-021-02428-3","article-title":"CD55-deficiency in Jews of Bukharan descent is caused by the Cromer blood type Dr(a-) variant","volume":"142","author":"Kurolap","year":"2023","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2025.04.020_bib33","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-059335","article-title":"CD55 deficiency with Budd-Chiari syndrome treated by liver transplantation and eculizumab","volume":"152","author":"Ohlsson","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2025.04.020_bib34","doi-asserted-by":"crossref","unstructured":"De Boer ECW, Van Der Kruk N, Pouw RB, Van Limbergen JE, Kuijpers TW. A pedigree with complement hyperactivation, angiopathic thrombosis, and severe protein-losing enteropathy (CHAPLE) disease: variable penetrance and treatment with pozelimab [published online ahead of print]. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2024.11.015.","DOI":"10.1016\/j.cgh.2024.11.015"},{"key":"10.1016\/j.jaci.2025.04.020_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.21307\/immunohematology-2021-017","article-title":"The Cromer blood group system: an update","volume":"37","author":"Storry","year":"2021","journal-title":"Immunohematology"},{"key":"10.1016\/j.jaci.2025.04.020_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bjh.18509","article-title":"Anti-IFC antibodies in a patient with CHAPLE syndrome: implications for blood management","volume":"200","author":"Minovic","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2025.04.020_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/j.2040-4603.2019.tb00063.x","article-title":"Lymphatic vessel network structure and physiology","volume":"9","author":"Breslin","year":"2018","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jaci.2025.04.020_bib38","article-title":"Molecular mechanisms controlling lymphatic endothelial junction integrity","volume":"8","author":"Norden","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jaci.2025.04.020_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-023-01723-x","article-title":"Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2025.04.020_bib40","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2012-05-428607","article-title":"Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos","volume":"120","author":"Yang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.04.020_bib41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature07391","article-title":"Sox18 induces development of the lymphatic vasculature in mice","volume":"456","author":"Francois","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.04.020_bib42","first-page":"156","article-title":"Immune proteins, enzymes and electrolytes in human peripheral lymph","volume":"11","author":"Olszewski","year":"1978","journal-title":"Lymphology"},{"key":"10.1016\/j.jaci.2025.04.020_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0037-1613832","article-title":"Haemostatic factors in human peripheral afferent lymph","volume":"83","author":"Miller","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2025.04.020_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0032-1301418","article-title":"Hemostatic properties of the lymph: relationships with occlusion and thrombosis","volume":"38","author":"Lippi","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jaci.2025.04.020_bib45","article-title":"Lymphatic vessel thrombosis in a patient with secondary lymphedema","volume":"7","author":"Hara","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.jaci.2025.04.020_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/lrb.2019.0074","article-title":"Axillary web syndrome: evidence for lymphatic origin with thrombosis","volume":"18","author":"Johansson","year":"2020","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jaci.2025.04.020_bib47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2301594","article-title":"Protein-losing enteropathy","volume":"389","author":"Ozen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.04.020_bib48","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00467-024-06451-0","article-title":"Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation","volume":"39","author":"Wang","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jaci.2025.04.020_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350816","article-title":"Complement-targeted therapeutics: are we there yet, or just getting started?","volume":"54","author":"Ricklin","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.04.020_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269749","article-title":"Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates","volume":"17","author":"Devalaraja-Narashimha","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.04.020_bib51","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s40265-023-01955-9","article-title":"Pozelimab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2025.04.020_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231892","article-title":"Inhibition of complement pathway activation with pozelimab, a fully human antibody to complement component C5","volume":"15","author":"Latuszek","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.04.020_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14712598.2024.2438740","article-title":"An evaluation of pozelimab for the treatment of CHAPLE disease","volume":"25","author":"Can","year":"2025","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaci.2025.04.020_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/jbcpp-2024-0008","article-title":"Pozelimab, a human monoclonal immunoglobulin for the treatment of CHAPLE disease","volume":"35","author":"Kaur","year":"2024","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.jaci.2025.04.020_bib55","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(23)02652-1","article-title":"A new drug for rare diseases: pozelimab for CHAPLE disease","volume":"403","author":"Belot","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.04.020_bib56","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1080\/14656566.2024.2388267","article-title":"Pharmacotherapy for CD55 deficiency with CHAPLE disease: how close are we to a cure?","volume":"25","author":"Can","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaci.2025.04.020_bib57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10928-024-09941-8","article-title":"Population pharmacokinetic analyses of pozelimab in patients with CD55-deficient protein-losing enteropathy (CHAPLE disease)","volume":"51","author":"Lin","year":"2024","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.jaci.2025.04.020_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13023-024-03277-9","article-title":"Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments","volume":"19","author":"Litcher-Kelly","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2025.04.020_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MPG.0000000000002198","article-title":"Eculizumab is safe and effective as a long-term treatment for protein-losing enteropathy due to CD55 deficiency","volume":"68","author":"Kurolap","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2025.04.020_bib60","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/joneph\/20.2.246","article-title":"Recurrent hemolytic uremic syndrome associated with intestinal lymphangiectasia","volume":"20","author":"Kalman","year":"2007","journal-title":"J Nephrol"},{"key":"10.1016\/j.jaci.2025.04.020_bib61","first-page":"416","article-title":"Intractable diarrhea of infancy due to lymphangiectasis","volume":"127","author":"Fried","year":"1974","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2025.04.020_bib62","series-title":"StatPearls [Internet]","article-title":"Hemolytic Uremic Syndrome. [Updated 2023 Oct 19]","author":"Bhandari","year":"2025"},{"key":"10.1016\/j.jaci.2025.04.020_bib63","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jaci.2025.04.020_bib64","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1177\/0300060519864808","article-title":"Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy","volume":"47","author":"Hanna","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jaci.2025.04.020_bib65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfw453","article-title":"Eculizumab in secondary atypical haemolytic uraemic syndrome","volume":"32","author":"Cavero","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaci.2025.04.020_bib66","first-page":"481","article-title":"Recurrent hemolytic uremic syndrome with hypocomplementemia and intestinal lymphangiectasia","volume":"76","author":"Bogdanovic","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.jaci.2025.04.020_bib67","series-title":"StatPearls [Internet]","article-title":"Systemic Lupus Erythematosus. [Updated 2023 Aug 4]","author":"Justiz Vaillant","year":"2025"},{"key":"10.1016\/j.jaci.2025.04.020_bib68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/24725625.2020.1738988","article-title":"Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report","volume":"4","author":"Funada","year":"2020","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.jaci.2025.04.020_bib69","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/1756-185X.14541","article-title":"A case of systemic lupus erythematosus presenting with intestinal lymphangiectasia-associated protein-losing enteropathy accompanying hyperinflammation","volume":"26","author":"Bektas","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaci.2025.04.020_bib70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MEG.0b013e32834f3ea0","article-title":"Protein-losing enteropathy associated with or without systemic autoimmune disease: what are the differences?","volume":"24","author":"Law","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925004609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925004609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:33:32Z","timestamp":1778142812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925004609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0091674925004609"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.04.020","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement dysregulation at lymphatics","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}